Asthma Insurance Claim Denied in Michigan? Your Rights Under DIFS and Medicaid

Michigan's industrial past and ongoing manufacturing economy have left communities from Detroit to Flint to Saginaw with high rates of asthma and COPD. Despite the medical need, Michigan insurers routinely deny biologics like Dupixent, Fasenra, and Nucala through step therapy, Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization, and formulary barriers. Michigan law gives you the right to fight these denials — here's how.

Why Michigan Insurers Deny Asthma Claims

Common denial patterns in Michigan include:

• Step therapy for biologics: Insurers require patients to cycle through multiple older medications before approving FDA-approved biologics
• PIHP formulary restrictions: Prepaid Inpatient Health Plans (PIHPs) that deliver Medicaid services apply their own formulary restrictions that sometimes go beyond standard Medicaid coverage
• Prior authorization denials for nebulizers: Home nebulizers classified as duplicative or unnecessary alongside inhaler therapy
• Rescue inhaler quantity limits: Albuterol restricted for patients with frequent exacerbations
• Out-of-network specialist denials: Metro Detroit and rural Upper Peninsula patients often lack accessible in-network specialists

Michigan Insurance Regulator: DIFS

The Michigan Department of Insurance and Financial Services (DIFS) regulates commercial health insurers and administers the External Independent Review: Complete Guide" class="auto-link">external review process in Michigan.

DIFS Consumer Help Line:

• Phone: 1-877-999-6442
• Website: michigan.gov/difs
• File a complaint or appeal: michigan.gov/difs/consumers

Michigan requires insurers to offer external review of adverse benefit determinations. External reviews are conducted by IROs) Explained" class="auto-link">Independent Review Organizations and are binding on the insurer. Standard reviews are completed within 45 days; expedited reviews within 72 hours for urgent cases.

Michigan Medicaid and PIHP Biologic Challenges

Michigan Medicaid (the Michigan Medicaid program administered by MDHHS) uses a two-tier managed care structure:

• Prepaid Inpatient Health Plans (PIHPs): Cover behavioral health and some specialty services — not the primary vehicle for asthma biologics, but relevant for Medicaid managed care members
• Medicaid Health Plans (MHPs): Cover most physical health services including medications — these are where asthma biologic coverage decisions are made

Michigan Medicaid Health Plans include Blue Cross Complete, HAP Midwest Health Plan, McLaren Health Plan, Meridian Health Plan, Molina Healthcare, and Priority Health Choice.

For Michigan Medicaid denials:

• File a grievance with your Medicaid Health Plan within 90 days
• Request a State Fair Hearing through MDHHS: 1-800-642-3195
• Contact Michigan Poverty Law Program: mplp.org for legal assistance
• Contact Legal Services of South Central Michigan: lsscm.org

Michigan Medicaid Biologic Coverage

Michigan Medicaid covers FDA-approved asthma biologics for members who meet clinical criteria with prior authorization. Common documentation requirements include:

• Diagnosis of severe persistent asthma (GINA Step 4 or 5)
• Documented failure of optimal inhaled therapy (ICS + LABA)
• Lab values (eosinophils, IgE where applicable)
• Absence of contraindications
• Prescribing pulmonologist or allergist attestation

If your Medicaid plan denied a biologic, the denial criteria used by the plan may be more restrictive than what MDHHS actually requires. A State Fair Hearing gives an independent hearing officer the power to override the plan's decision.

Flint, Detroit, and Environmental Asthma Justice

Detroit's 48217 zip code has been identified as one of the most polluted zip codes in the United States, driven by Marathon Petroleum, multiple industrial facilities, and high diesel truck traffic near port operations. Southwest Detroit has among the highest pediatric asthma rates in Michigan. Flint's water crisis has added to the respiratory health burden through mold proliferation in damaged housing.

These environmental realities make the medical necessity case for intensive asthma treatment — including biologics — especially compelling. Document your home address and any documented local air quality concerns in your appeal narrative.

FDA-Approved Biologics: Building Your Michigan Appeal

• Dupixent (dupilumab): Moderate-to-severe eosinophilic asthma; OCS-dependent asthma without eosinophil minimum. Detroit patients with coexisting atopic dermatitis qualify under multiple indications simultaneously
• Fasenra (benralizumab): Severe eosinophilic asthma — every-8-week maintenance dosing after initial loading
• Nucala (mepolizumab): Severe eosinophilic asthma; COPD with eosinophilic phenotype — critical for Michigan's manufacturing and auto worker population
• Tezspire (tezepelumab): Uncontrolled severe asthma — no eosinophil threshold required
• Xolair (omalizumab): Allergic asthma with positive IgE sensitization — relevant for allergic asthma prevalent in Michigan's high-pollen areas

Step-by-Step Appeal Process in Michigan

1. Get denial in writing: EOB and written denial letter with clinical rationale
2. File internal appeal: Within 60–180 days; include physician letter, lab values, prior medication history
3. Peer-to-peer review: Physician contacts medical director directly
4. Step therapy exception request: Formal submission citing Michigan's step therapy protections
5. DIFS external review: After internal appeal; binding on insurer
6. DIFS complaint: michigan.gov/difs/consumers — investigated by DIFS staff

Michigan Advocacy Resources

• American Lung Association – Michigan: lung.org | 1-800-586-4872
• Michigan Environmental Council: environmentalcouncil.org — air quality and health equity
• Michigan Poverty Law Program: mplp.org — legal help for low-income Michiganders
• NAACP Detroit Branch: naacpdetroit.org — health equity advocacy in environmental justice communities
• Great Lakes Environmental Law Center: glelc.org — environmental health legal support

Fight Back With ClaimBack

Michigan's asthma patients — from Detroit's 48217 to the rural Upper Peninsula — deserve the treatments their physicians prescribe. ClaimBack helps you craft an appeal that meets Michigan's specific regulatory standards, documents medical necessity correctly, and invokes your rights under DIFS oversight.

Start your appeal at ClaimBack — powerful tools for people who've been wrongly denied.

Related Reading:

• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: Which Should You File?
• What Is Medical Necessity?